Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 2 (February)

1. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients.
   Int J Radiat Oncol Biol Phys, 76(2): 504-12. [Abstract] [Full-text]
2. An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma.
   J Neuroimmunol, 218(1): 125-8. [Abstract] [Full-text]
3. Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases.
   Int J Radiat Oncol Biol Phys, 76(2): 513-9. [Abstract] [Full-text]
4. Factors associated with neurological recovery of brainstem function following postoperative conformal radiation therapy for infratentorial ependymoma.
   Int J Radiat Oncol Biol Phys, 76(2): 496-503. [Abstract] [Full-text]
5. Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.
   Cancer, 116(3): 695-704. [Abstract] [Full-text]
6. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders.
   Neuroscience, 165(4): 1233-43. [Abstract] [Full-text]
7. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol.
   Cancer, 116(3): 705-12. [Abstract] [Full-text]
8. Therapeutic effect of linac-based stereotactic radiotherapy with a micro-multileaf collimator for the treatment of patients with brain metastases from lung cancer.
   Jpn J Clin Oncol, 40(2): 119-24. [Abstract] [Full-text]
9. Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
   Eur J Surg Oncol, 36(2): 201-7. [Abstract] [Full-text]
10. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Cancer Lett, 288(2): 251-60. [Abstract] [Full-text]
11. Image-guided resection of small lesions in the cavernous sinus and Meckel's cave.
    Eur J Surg Oncol, 36(2): 208-13. [Abstract] [Full-text]
12. The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.
    Cancer Lett, 288(2): 170-6. [Abstract] [Full-text]
13. Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.
    J Pharm Biomed Anal, 51(4): 958-64. [Abstract] [Full-text]
14. Dosimetric impact of intrafractional patient motion in pediatric brain tumor patients.
    Med Dosim, 35(1): 43-8. [Abstract] [Full-text]
15. Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience.
    Strahlenther Onkol, 186(2): 76-81. [Abstract] [Full-text]
16. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
    Strahlenther Onkol, 186(2): 70-5. [Abstract] [Full-text]
17. DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.
    Strahlenther Onkol, 186(2): 63-9. [Abstract] [Full-text]
18. Anaplastic oligodendrogliomas after treatment of acute lymphoblastic leukemia in children: report of 2 cases.
    J Neurosurg Pediatr, 5(2): 179-83. [Abstract] [Full-text]
19. Malignant transformation of irradiated craniopharyngioma in children: report of 2 cases.
    J Neurosurg Pediatr, 5(2): 155-61. [Abstract] [Full-text]
20. Medulloblastoma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors in a child: case report.
    J Neurosurg Pediatr, 5(2): 149-54. [Abstract] [Full-text]
21. ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth.
    Cancer Res, 70(3): 1236-46. [Abstract] [Full-text]
22. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
    Proc Natl Acad Sci U S A, 107(5): 2183-8. [Abstract] [Full-text]
23. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    J Clin Endocrinol Metab, 95(2): 630-8. [Abstract] [Full-text]
24. Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.
    J Clin Endocrinol Metab, 95(2): 968-76. [Abstract] [Full-text]
25. Phase II study of plitidepsin 3-hour infusion every 2 weeks in patients with unresectable advanced medullary thyroid carcinoma.
    Am J Clin Oncol, 33(1): 83-8. [Abstract] [Full-text]
26. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
    Am J Clin Oncol, 33(1): 70-4. [Abstract] [Full-text]
27. Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
    Leukemia, 24(2): 450-9. [Abstract] [Full-text]
28. Infratentorial oligodendrogliomas: Imaging findings in six patients.
    Acta Radiol, 51(2): 213-7. [Abstract] [Full-text]
29. Deregulated signalling networks in human brain tumours.
    Biochim Biophys Acta, 1804(3): 476-83. [Abstract] [Full-text]
30. Equivalence in dose fall-off for isocentric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes.
    Int J Radiat Oncol Biol Phys, 76(3): 943-8. [Abstract] [Full-text]
31. Differences in supratentorial damage of white matter in pediatric survivors of posterior fossa tumors with and without adjuvant treatment as detected by magnetic resonance diffusion tensor imaging.
    Int J Radiat Oncol Biol Phys, 76(3): 859-66. [Abstract] [Full-text]
32. Glioblastoma with signet-ring morphology: a case report and review of the literature.
    Hum Pathol, 41(3): 443-6. [Abstract] [Full-text]
33. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Pediatr Blood Cancer, 54(4): 649-51. [Abstract] [Full-text]
34. Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
    Pediatr Blood Cancer, 54(4): 641-3. [Abstract] [Full-text]
35. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.
    Pediatr Blood Cancer, 54(4): 638-40. [Abstract] [Full-text]
36. Medulloblastoma in young children.
    Pediatr Blood Cancer, 54(4): 635-7. [Abstract] [Full-text]
37. Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain tumors.
    Pediatr Blood Cancer, 54(4): 654-6. [Abstract] [Full-text]
38. Successful mobilization, harvest and transplant of peripheral blood stem cells using AMD3100 and G-CSF following high dose craniospinal irradiation for medulloblastoma in a young child.
    Pediatr Blood Cancer, 54(4): 613-5. [Abstract] [Full-text]
39. Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy.
    Pediatr Blood Cancer, 54(4): 616-7. [Abstract] [Full-text]
40. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.
    Pediatr Blood Cancer, 54(4): 519-25. [Abstract] [Full-text]
41. Comparison of functional outcomes in low- and high-grade astrocytoma rehabilitation inpatients.
    Am J Phys Med Rehabil, 89(3): 205-12. [Abstract] [Full-text]
42. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
    Mol Carcinog, 49(3): 302-14. [Abstract] [Full-text]
43. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
    Eur J Endocrinol, 162(3): 483-90. [Abstract] [Full-text]
44. Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease.
    Eur J Endocrinol, 162(3): 603-9. [Abstract] [Full-text]
45. Janus flap: bilateral nasoseptal flaps for anterior skull base reconstruction.
    Otolaryngol Head Neck Surg, 142(3): 327-31. [Abstract] [Full-text]
46. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.
    J Clin Oncol, 28(7): 1168-74. [Abstract] [Full-text]
47. A comparison of 3% hypertonic saline and mannitol for brain relaxation during elective supratentorial brain tumor surgery.
    Anesth Analg, 110(3): 903-7. [Abstract] [Full-text]
48. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Cancer, 116(5): 1358-66. [Abstract] [Full-text]
49. Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose.
    Cancer Lett, 289(2): 246-53. [Abstract] [Full-text]
50. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
    Int J Cancer, 126(8): 1944-54. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.